Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds CJS Securities Downgrades Unisys to Market Perform

CJS Securities Downgrades Unisys to Market Perform

CJS Securities analyst Jonathan Tanwanteng downgrades Unisys (NYSE:UIS) from Market Outperform to Market Perform.

byBenzinga Newsdesk

November 9, 2022

1 minute read

CJS Securities analyst Jonathan Tanwanteng downgrades Unisys (NYSE:UIS) from Market Outperform to Market Perform.

Datadog Clocks Handsome Q3 Performance, Boosts FY22 Outlook

By Anusuya Lahiri

November 3, 1:00 PM

Datadog, Inc (NASDAQ:DDOG) reported third-quarter FY22 revenue growth of 61% year-on-year to $436.5 million, beating the consensus of $412.8 million.…

DDOG

Cameco Attracts Bullish Bets From Options Traders Ahead Of Earnings

By Priya Nigam

August 2, 9:41 AM

Cameco Corporation (NYSE: CCJ) is expected to report quarterly earnings on Aug. 2.

CCJ

Analyst Ratings

Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)

By Benzinga Insights

May 14, 8:00 AM

14 analysts have shared their evaluations of Legend Biotech (NASDAQ:LEGN) during the recent three months, expressing a mix…

LEGN

FDA Greenlights Expanded Use Of Neurocrine Biosciences’ Ingrezza: Analysts Weigh In Depression Warning

By Vandana Singh

August 21, 2:24 PM

The FDA approved Neurocrine Biosciences Inc's (NASDAQ: NBIX) Ingrezza (valbenazine) capsules for the treatment of adults with chorea associated

NBIX

CJS Securities Downgrades Unisys to Market Perform

Related Posts

Datadog Clocks Handsome Q3 Performance, Boosts FY22 Outlook

Cameco Attracts Bullish Bets From Options Traders Ahead Of Earnings

Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)

FDA Greenlights Expanded Use Of Neurocrine Biosciences’ Ingrezza: Analysts Weigh In Depression Warning